Prognostic factors in Chinese patients with immunoglobulin light chain amyloidosis: a scoping review and meta-analysis
Author:
Affiliation:
1. West China Hospital, Sichuan University, Chengdu, Sichuan, China
2. Xi’an Janssen Pharmaceutical Ltd, Beijing, Chaoyang District, China
3. The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
Funder
Xi’an Janssen Pharmaceutical Ltd
Publisher
Informa UK Limited
Link
https://www.tandfonline.com/doi/pdf/10.1080/07853890.2024.2386635
Reference89 articles.
1. Immunoglobulin light chain amyloidosis: 2020 update on diagnosis, prognosis, and treatment
2. Multiorgan involvement by amyloid light chain amyloidosis
3. Increased Serum Free Light Chains Precede the Presentation of Immunoglobulin Light Chain Amyloidosis
4. Amyloidosis (AL). Clinical and laboratory features in 229 cases;Kyle RA;Mayo Clin Proc,1983
5. Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3